Hospital M&A studies highlight higher prices, tepid antitrust intervention
A pair of academic studies published this week painted an unflattering picture of hospital dealmaking’s impact on healthcare prices and regulators’ track record of stepping in to protect market com | Two academic studies published this week sought to characterize cross-market deals and whether the FTC is taking a strong enough stance on blocking uncompetitive deals. Both painted an unflattering picture of post-merger prices and were refuted by the hospital lobby.